Through GESA, we noted that the high expression of PCSK6 was correlated with the up-regulation of the Kras signaling pathway compared to the low expression of PCSK6 in the cell lines of pancreatic cancer (Figure 8A,B). The gene discussed is PCSK6; the disease is pancreatic neoplasm.